Pfizer Market Cap 2006-2019 | PFE

Pfizer market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Pfizer market cap as of May 23, 2019 is $249.96B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $249.961B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $372.279B 16.88
Merck (MRK) United States $218.337B 17.96
Novartis AG (NVS) Switzerland $193.832B 16.75
AbbVie (ABBV) United States $120.617B 9.97
Novo Nordisk (NVO) Denmark $118.267B 19.67
Eli Lilly (LLY) United States $114.539B 21.26
Sanofi (SNY) France $105.565B 12.95
GlaxoSmithKline (GSK) United Kingdom $99.720B 12.64
AstraZeneca (AZN) United Kingdom $97.795B 11.26
Bristol-Myers Squibb (BMY) United States $78.089B 11.53